PreprintAll rights reservedbioRxiv
Complementary cytotoxicity of GD2-targeted photoimmunotherapy and 5-aminolevulinic acid photodynamic therapy in neuroblastoma and osteosarcoma
- 1University of Pittsburgh
Related
- Optimal number of 5-aminolevulinic acid photodynamic therapy sessions for cervical low-grade squamous intraepithelial lesions with high-risk HPV infection: a retrospective cohort study
- Case Report: Successful treatment of verruciform acanthotic vulvar intraepithelial neoplasia with 5-aminolevulinic acid photodynamic therapy.
- Real-world clinical outcomes of 5-aminolevulinic acid photodynamic therapy in patients with cervical intraepithelial neoplasia grade 1
- Recent Advances in Nanomedicine-Enhanced Photodynamic Therapy in Cutaneous Oncology: Melanoma-Dominant Evidence for Immunogenic Cell Death and Photoimmunotherapy.
- Bone marrow CD14+CD206+ M2-like monocyte-macrophages as a potential complementary biomarker for bone marrow MRD in high-risk neuroblastoma
BibTeX
@misc{pant2026complementary,
title = {{Complementary cytotoxicity of GD2-targeted photoimmunotherapy and 5-aminolevulinic acid photodynamic therapy in neuroblastoma and osteosarcoma}},
author = {A. Pant and C. Yip and B. Chagantipati and M. Mattioli and V. Kelly and E. Noaman and A. Kahler-Quesada and B. Grano-Mickelsen and S. Jackson and P. L. Choyke and H. Kobayashi and C. Hadjipanayis and L. T. Rosenblum and M. M. Malek and G. Kohanbash},
howpublished = {bioRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.01.748695},
url = {https://www.biorxiv.org/content/10.64898/2026.09.01.748695v1},
}
RIS
TY - UNPB
TI - Complementary cytotoxicity of GD2-targeted photoimmunotherapy and 5-aminolevulinic acid photodynamic therapy in neuroblastoma and osteosarcoma
AU - A. Pant
AU - C. Yip
AU - B. Chagantipati
AU - M. Mattioli
AU - V. Kelly
AU - E. Noaman
AU - A. Kahler-Quesada
AU - B. Grano-Mickelsen
AU - S. Jackson
AU - P. L. Choyke
AU - H. Kobayashi
AU - C. Hadjipanayis
AU - L. T. Rosenblum
AU - M. M. Malek
AU - G. Kohanbash
PY - 2026
DA - 2026/09/01
PB - bioRxiv
DO - 10.64898/2026.09.01.748695
UR - https://www.biorxiv.org/content/10.64898/2026.09.01.748695v1
ER -